Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Long-Term Deferred Tax (2023 - 2025)

Historic Long-Term Deferred Tax for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to $18.4 million.

  • Ardent Health's Long-Term Deferred Tax fell 4705.44% to $18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 million, marking a year-over-year decrease of 4705.44%. This contributed to the annual value of $12.3 million for FY2024, which is 6207.87% down from last year.
  • As of Q3 2025, Ardent Health's Long-Term Deferred Tax stood at $18.4 million, which was down 4705.44% from $17.1 million recorded in Q2 2025.
  • Over the past 5 years, Ardent Health's Long-Term Deferred Tax peaked at $34.8 million during Q3 2024, and registered a low of $12.3 million during Q4 2024.
  • Over the past 3 years, Ardent Health's median Long-Term Deferred Tax value was $18.4 million (recorded in 2025), while the average stood at $23.7 million.
  • As far as peak fluctuations go, Ardent Health's Long-Term Deferred Tax crashed by 6207.87% in 2024, and later crashed by 4705.44% in 2025.
  • Over the past 3 years, Ardent Health's Long-Term Deferred Tax (Quarter) stood at $32.5 million in 2023, then crashed by 62.08% to $12.3 million in 2024, then soared by 49.39% to $18.4 million in 2025.
  • Its Long-Term Deferred Tax was $18.4 million in Q3 2025, compared to $17.1 million in Q2 2025 and $15.8 million in Q1 2025.